ArticleCell communication and signaling : CCS2026
Ift46 deficiency causes renal cyst via enhanced Limk2 through lack of autophagy flux.
Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundIntraflagellar transport protein 46 (IFT46) is a core protein of the IFT B complex linked to signal transduction systems with primary cilia. Although the function of Ift46 has been extensively fully investigated, the study of Ift46 other than ciliogenesis has not. Recent studies have shown that Ift46 could control autophagy progression in addition to the mechanism of cilia formation.
methodsTo investigate the biological function of Ift46, we performed and analyzed total RNA sequencing using Ift46 knockdown mouse inner medullary collecting duct cells. Gene ontology analysis revealed that Ift46 is associated with partial epithelial–mesenchymal transition (EMT). In vitro experiments demonstrated that Ift46 regulated partial EMT, LIM domain kinase 2 (Limk2) and autophagy flux. The direct interaction between Limk2 and p62/sequestosome 1 was verified through co-immunoprecipitation, and various drugs affecting autophagy were found to impact Limk2 stability. The role of Ift46, autophagy, and Limk2 in the renal cyst formation and the progression of EMT was highlighted using an in vitro three-dimensional culture system. Furthermore, the Ift46-autophagy-Limk2 axis was validated in a collecting duct-specific Ift46-deficient mouse and in human autosomal dominant polycystic kidney disease.
resultsIft46 regulated autophagy in mouse collecting duct cells, and Ift46 deficiency surprisingly led to an increase in Limk2 translation. Moreover, the translational changes in Limk2 were influenced by the regulation of autophagy. In Ift46-deficient mice, which exhibit a polycystic kidney disease phenotype, the upregulated Limk2 promoted mesenchymal characteristics despite minimal epithelial changes. Furthermore, the induction of autophagy suppressed Limk2, leading to the proposal of the ‘Ift46-autophagy-Limk2’ axis.
conclusionsOur study provides a novel finding that Ift46-regulated autophagy controls partial EMT through Limk2 regulation, suggesting a Limk2-dependent mechanism of cystogenesis in PKD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.